Considering its AML-specific training, the very low false-positive rate on newly presented and differently structured image data of healthy controls underlines the distinct morphology picked up by the classifier for correct predictions in NPM1-mutated AML. This evidence concerns the gene NPM1 and acute myeloid leukemia.